Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell–Mediated Antibody-Dependent Cellular Cytotoxicity-Reference-Cited by-同舟云学术

Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell–Mediated Antibody-Dependent Cellular Cytotoxicity

Published:2019-11-20 Issue:12 Volume:203 Page:3126-3135
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Temming A. Robin^ORCID,de Taeye Steven W.^ORCID,de Graaf Erik L.^ORCID,de Neef Louise A.^ORCID,Dekkers Gillian^ORCID,Bruggeman Christine W.,Koers Jana,Ligthart Peter,Nagelkerke Sietse Q.^ORCID,Zimring James C.,Kuijpers Taco W.,Wuhrer Manfred,Rispens Theo,Vidarsson Gestur^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Low anti‐ R h D I g G ‐ F c‐fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn

2. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.;Sonneveld;Br. J. Haematol.,2017

3. IgG Fc engineering to modulate antibody effector functions

4. Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities

5. Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing;Communications Biology;2024-08-09

2. Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells;Journal for ImmunoTherapy of Cancer;2024-07

3. Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells;2024-05-14

4. The arming of NK cells with Fc-engineered rituximab confers them specificity against CD20-expressing cells;2024-03-11

5. Natural killer cell therapies;Nature;2024-02-21